Search Ontology:
ChEBI

misoprostol

Term ID
CHEBI:63610
Synonyms
  • (+-)-methyl (1R,2R,3R)-3-hydroxy-2-((E)-(4RS)-4-hydroxy-4-methyl-1-octenyl)-5-oxocyclopentaneheptanoate
  • (11-alpha,13E)-(+-)-11,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oic acid methyl ester
  • Arthrotec
  • Cytotec
  • Methyl (+-)-11-alpha,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oate
  • misoprostol
  • misoprostolum
Definition
A diastereoisomeric mixture composed of approximately equal amounts of a double racemate of four of the sixteen possible diastereoisomers of methyl (13E)-11,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oate that is racemic prostaglandin E1 which is lacking the hydroxy group at position 15, but which has an additional hydroxy group at position 16. It is a synthetic prostaglandin E1 analogue, used in the treatment of gastric and duodenal ulcers. A weak abortifacient, it is also used for cervical ripening prior to surgical termination of pregnancy. The (11R,16S)-diastereoisomer is the pharmacologically active form.
References
  • cas:59122-46-2
  • drugbank:DB00929
  • kegg.drug:D00419
  • patent:BE827127
  • patent:US3965143
  • pubmed:10945193
  • pubmed:10949752
  • pubmed:11136959
  • pubmed:1417145
  • pubmed:18690850
  • pubmed:19740175
  • pubmed:2109814
  • pubmed:3080288
  • reaxys:4155643
  • wikipedia.en:Misoprostol
Ontology
ChEBI  ( EBI )
Resources
CTD
Relationships
Phenotype
Phenotype resulting from misoprostol
Phenotype where environments contain misoprostol
Phenotype modified by environments containing misoprostol
Phenotype affecting misoprostol
Human Disease Model